An Extension Trial to NN1250-3585 Investigating Safety and Efficacy of NN1250 Compared to Insulin Detemir in Subjects With Type 1 Diabetes Mellitus in a Basal/Bolus Treatment Regimen (BEGIN™: BB T1)

Brief Summary

This trial is conducted in Asia, Europe, Japan and South America. The aim of the trial is to investigate safety and efficacy of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus.